Bigelow Investment Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $695K | Sell |
1,321
-47
| -3% | -$26.4K | 0.25% | 95 |
|
|
2026
Q1 | $769K | Buy |
1,368
+32
| +2% | +$20.5K | 0.31% | 85 |
|
|
2025
Q4 | $904K | Sell |
1,336
-39
| -3% | -$26.6K | 0.35% | 72 |
|
|
2025
Q3 | $878K | Sell |
1,375
-27
| -2% | -$16.4K | 0.35% | 75 |
|
|
2025
Q2 | $752K | Sell |
1,402
-18
| -1% | -$8.61K | 0.33% | 80 |
|
|
2025
Q1 | $596K | Buy |
1,420
+27
| +2% | +$11.7K | 0.28% | 93 |
|
|
2024
Q4 | $576K | Sell |
1,393
-191
| -12% | -$83.8K | 0.27% | 97 |
|
|
2024
Q3 | $800K | Buy |
1,584
+38
| +2% | +$18.5K | 0.36% | 82 |
|
|
2024
Q2 | $753K | Sell |
1,546
-30
| -2% | -$15.1K | 0.36% | 81 |
|
|
2024
Q1 | $851K | Sell |
1,576
-18
| -1% | -$9.84K | 0.42% | 74 |
|
|
2023
Q4 | $885K | Sell |
1,594
-1
| -0.1% | -$469 | 0.48% | 65 |
|
|
2023
Q3 | $697K | Hold |
1,595
| – | – | 0.4% | 76 |
|
|
2023
Q2 | $801K | Buy |
1,595
+64
| +4% | +$30.7K | 0.44% | 71 |
|
|
2023
Q1 | $766K | Sell |
1,531
-158
| -9% | -$75.6K | 0.44% | 75 |
|
|
2022
Q4 | $689K | Buy |
1,689
+48
| +3% | +$18.6K | 0.4% | 78 |
|
|
2022
Q3 | $535K | Buy |
1,641
+36
| +2% | +$13.2K | 0.32% | 91 |
|
|
2022
Q2 | $563K | Buy |
1,605
+68
| +4% | +$27.7K | 0.31% | 90 |
|
|
2022
Q1 | $841K | Buy |
1,537
+137
| +10% | +$72.1K | 0.39% | 64 |
|
|
2021
Q4 | $922K | Sell |
1,400
-59
| -4% | -$37K | 0.42% | 61 |
|
|
2021
Q3 | $907K | Sell |
1,459
-36
| -2% | -$24.2K | 0.45% | 62 |
|
|
2021
Q2 | $944K | Hold |
1,495
| – | – | 0.46% | 61 |
|
|
2021
Q1 | $732K | Buy |
1,495
+19
| +1% | +$9.52K | 0.37% | 72 |
|
|
2020
Q4 | $738K | Sell |
1,476
-33
| -2% | -$14.8K | 0.39% | 68 |
|
|
2020
Q3 | $593K | Buy |
1,509
+6
| +0.4% | +$2.22K | 0.35% | 72 |
|
|
2020
Q2 | $496K | Sell |
1,503
-175
| -10% | -$50.7K | 0.32% | 84 |
|
|
2020
Q1 | $406K | Buy |
1,678
+205
| +14% | +$53.5K | 0.3% | 85 |
|
|
2019
Q4 | $385K | Hold |
1,473
| – | – | 0.23% | 113 |
|
|
2019
Q3 | $401K | Buy |
1,473
+110
| +8% | +$30.6K | 0.25% | 107 |
|
|
2019
Q2 | $375K | Buy |
1,363
+37
| +3% | +$9.12K | 0.25% | 107 |
|
|
2019
Q1 | $296K | Sell |
1,326
-1,972
| -60% | -$407K | 0.21% | 124 |
|
|
2018
Q4 | $613K | Buy |
3,298
+132
| +4% | +$27.1K | 0.46% | 66 |
|
|
2018
Q3 | $790K | Sell |
3,166
-10
| -0.3% | -$2.43K | 0.53% | 56 |
|
|
2018
Q2 | $692K | Buy |
3,176
+77
| +2% | +$15.9K | 0.47% | 64 |
|
|
2018
Q1 | $593K | Buy |
+3,099
| New | +$572K | 0.4% | 73 |
|
Other funds holding IDXX
Bigelow Investment Advisors's IDXX Position: Q2 2026 in Review
Bigelow Investment Advisors reduced its Idexx Laboratories (IDXX) stake by 3.4% in Q2 2026, selling an estimated $26.4K and leaving 1,321 shares worth $695K. The position accounts for 0.25% of the portfolio, ranked #95.
Bigelow Investment Advisors first reported a position in IDXX in Q1 2018 and has held it in 34 quarters since. The position peaked at $944K in Q2 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Bigelow Investment Advisors held 1,321 shares of Idexx Laboratories worth $695K as of Q2 2026.
- Bigelow Investment Advisors sold 47 Idexx Laboratories shares in Q2 2026, an estimated $26.4K.
- Idexx Laboratories made up 0.25% of Bigelow Investment Advisors's portfolio in Q2 2026, its #95 holding.
- Bigelow Investment Advisors first reported a position in Idexx Laboratories in Q1 2018 and has held it in 34 quarters since.
- Bigelow Investment Advisors's Idexx Laboratories position peaked at $944K in Q2 2021.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Bigelow Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.